Papillomavirus Infections

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Papillomavirus Infections trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 38 trials

RecruitingPhase 2

NCT07572396

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo…

The goal of this clinical trial is to learn if an investigational vaginal suppository therapy works to treat low-grade cervical lesions (ASC-US and LSIL) associ…

Hong Kong45 participantsStarted 2026-04-30

Treatment: EGCG and Quinine Sulfate Vaginal Suppository, Placebo

RecruitingNot Applicable

NCT00867269

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Background: * Idiopathic CD4+ lymphocytopenia (ICL) is a condition in which there is a decreased level of CD4+ lymphocytes (a type of white blood cell), which…

United States950 participantsStarted 2009-07-13

RecruitingPhase 1/2

NCT00967785

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

Background: * WHIMS (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome) is caused by various genetic changes that increase the activity of t…

United States20 participantsStarted 2010-01-06

Treatment: Mozobil (TM)

RecruitingPhase 2

NCT07454915

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

The purpose of this Phase 2 study is to compare the effects of administering the PVX4 combination device biologic product (pBI-4 DNA vaccine via electroporation…

United States, Taiwan138 participantsStarted 2026-04-01

Treatment: PVX4 Combination Product, Placebo Control

RecruitingPhase 3

NCT07457918

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

People who participated in either the COVE-2 or COVE-3 study for common warts, may be eligible to enroll into this Long Term Follow Up (LTFU) study COVE-4. The…

United States600 participantsStarted 2026-03-11

Treatment: Cantharidin

RecruitingNot Applicable

NCT07565350

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

1. Background of the Problem Viral warts result from infection of the skin or mucous membranes by human papillomavirus (HPV). Some patients develop refractory c…

China80 participantsStarted 2025-10-01

Treatment: An infrared hyperthermia device, Hydrogen Peroxide 3 % Topical Solution

All recent trials (100 shown)

Not Yet RecruitingNot Applicable

NCT07576842

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

The overall goal of this study is to inform the design and establish feasibility for a future clinical trial to determine the optimal management of women living…

Botswana750 participantsStarted 2026-06-01

Treatment: HPV DNA Testing (Abbott Alinity m HPV Assay), Visual Inspection with Acetic Acid

CompletedPhase 2

NCT03603808

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

This phase II trial studies the use of human papillomavirus (HPV) deoxyribonucleic acid (DNA) plasmids therapeutic vaccine VGX-3100 (VGX-3100) and electroporati…

United States44 participantsStarted 2018-09-21

Treatment: Electroporation, HPV DNA Plasmids Therapeutic Vaccine VGX-3100

Papillomavirus Infections

Trial phase breakdown

Trial status

Actively recruiting — 38 trials

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo…

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

All recent trials (100 shown)

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Trial phase breakdown

Trial status

Actively recruiting — 38 trials

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo…

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts

All recent trials (100 shown)

Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

Immunogenicity of Fractional Dose of the HPV Vaccines

Intradermal, Fractional Dose of HPV Vaccines:

Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies

CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda

Gamified Learning Methods and HPV Knowledge in Nursing Students

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya

Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell Lymphocytop…

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (C…

New Treatment of Common Wart